Chronic Obstructive Pulmonary Disease Market Outlook: Bronchodilators, Biologics, and Digital Health
Chronic obstructive pulmonary disease (COPD) remains one of the leading causes of morbidity and mortality worldwide, creating a significant burden on healthcare systems. Increasing exposure to tobacco smoke, air pollution, occupational hazards, and an aging global population has contributed to the growing prevalence of the disease. As a result, demand for innovative COPD therapy,...
0 Comentários 0 Compartilhamentos 26 Visualizações 0 Anterior